30 research outputs found
Molecular diagnosis of Pseudoterranova decipiens s.s in human, France
Background: Anisakis and Pseudoterranova are the main genera involved in human infections caused by nematodes
of the Anisakidae family. Species identification is complicated due to the lack of differential morphological
characteristics at the larval stage, thus requiring molecular differentiation. Pseudoterranova larvae ingested through
raw fish are spontaneously eliminated in most cases, but mechanical removal by means of endoscopy might be
required. To date, only very few cases of Pseudoterranova infection have been reported in France.
Case presentation: A 19-year-old woman from Northeastern France detected, while brushing her teeth, a larva
exiting through her mouth. The patient who presented with headache, diarrhea, and abdominal cramps reported
having eaten baked cod. The worm was a fourth-stage larva with a size of 22 × 0.9 mm, and molecular
biology identified it as Pseudoterranova decipiens sensu stricto (s. s.). In a second P. decipiens infection case, occurring a
few months later, a worm exited through the patient’s nose after she had eaten raw sea bream.
Conclusion: These two cases demonstrate that Pseudoterranova infection is not uncommon among French patients.
Therefore, molecular techniques should be more widely applied for a better characterization of anisakidosis epidemiology
in France
Inhibition of Specific NF-κB Activity Contributes to the Tumor Suppressor Function of 14-3-3σ in Breast Cancer
14-3-3σ is frequently lost in human breast cancers by genetic deletion or promoter methylation. We have now investigated the involvement of 14-3-3σ in the termination of NF-κB signal in mammary cells and its putative role in cancer relapse and metastasis. Our results show that 14-3-3σ regulates nuclear export of p65-NF-κB following chronic TNFα stimulation. Restoration of 14-3-3σ in breast cancer cells reduces migration capacity and metastatic abilities in vivo. By microarray analysis, we have identified a genetic signature that responds to TNFα in a 14-3-3σ-dependent manner and significantly associates with different breast and other types of cancer. By interrogating public databases, we have found that over-expression of this signature correlates with poor relapse-free survival in breast cancer patients. Finally, screening of 96 human breast tumors showed that NF-κB activation strictly correlates with the absence of 14-3-3σ and it is significantly associated with worse prognosis in the multivariate analysis. Our findings identify a genetic signature that is important for breast cancer prognosis and for future personalized treatments based on NF-κB targeting
Interferometric Observations of Rapidly Rotating Stars
Optical interferometry provides us with a unique opportunity to improve our
understanding of stellar structure and evolution. Through direct observation of
rotationally distorted photospheres at sub-milliarcsecond scales, we are now
able to characterize latitude dependencies of stellar radius, temperature
structure, and even energy transport. These detailed new views of stars are
leading to revised thinking in a broad array of associated topics, such as
spectroscopy, stellar evolution, and exoplanet detection. As newly advanced
techniques and instrumentation mature, this topic in astronomy is poised to
greatly expand in depth and influence.Comment: Accepted for publication in A&AR
Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection: A case control study
Introduction: The use of anti-retroviral therapy (ART) has dramatically reduced HIV-1 associated morbidity and mortality. However, HIV-1 infected individuals have increased rates of morbidity and mortality compared to the non-HIV-1 infected population and this appears to be related to end-organ diseases collectively referred to as Serious Non-AIDS Events (SNAEs). Circulating miRNAs are reported as promising biomarkers for a number of human disease conditions including those that constitute SNAEs. Our study sought to investigate the potential of selected miRNAs in predicting mortality in HIV-1 infected ART treated individuals. Materials and Methods: A set of miRNAs was chosen based on published associations with human disease conditions that constitute SNAEs. This case: control study compared 126 cases (individuals who died whilst on therapy), and 247 matched controls (individuals who remained alive). Cases and controls were ART treated participants of two pivotal HIV-1 trials. The relative abundance of each miRNA in serum was measured, by RTqPCR. Associations with mortality (all-cause, cardiovascular and malignancy) were assessed by logistic regression analysis. Correlations between miRNAs and CD4+ T cell count, hs-CRP, IL-6 and D-dimer were also assessed. Results: None of the selected miRNAs was associated with all-cause, cardiovascular or malignancy mortality. The levels of three miRNAs (miRs -21, -122 and -200a) correlated with IL-6 while miR-21 also correlated with D-dimer. Additionally, the abundance of miRs -31, -150 and -223, correlated with baseline CD4+ T cell count while the same three miRNAs plus miR- 145 correlated with nadir CD4+ T cell count. Discussion: No associations with mortality were found with any circulating miRNA studied. These results cast doubt onto the effectiveness of circulating miRNA as early predictors of mortality or the major underlying diseases that contribute to mortality in participants treated for HIV-1 infection
Territorial analysis of Aedes aegypti distribution in two Colombian cities: a chorematic and ecosystem approach
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study
Ristola M. on työryhmien DAD Study Grp ; Royal Free Hosp Clin Cohort ; INSIGHT Study Grp ; SMART Study Grp ; ESPRIT Study Grp jäsen.Background Chronic kidney disease (CKD) is a major health issue for HIV-positive individuals, associated with increased morbidity and mortality. Development and implementation of a risk score model for CKD would allow comparison of the risks and benefits of adding potentially nephrotoxic antiretrovirals to a treatment regimen and would identify those at greatest risk of CKD. The aims of this study were to develop a simple, externally validated, and widely applicable long-term risk score model for CKD in HIV-positive individuals that can guide decision making in clinical practice. Methods and Findings A total of 17,954 HIV-positive individuals from the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study with >= 3 estimated glomerular filtration rate (eGFR) values after 1 January 2004 were included. Baseline was defined as the first eGFR > 60 ml/min/1.73 m2 after 1 January 2004; individuals with exposure to tenofovir, atazanavir, atazanavir/ritonavir, lopinavir/ritonavir, other boosted protease inhibitors before baseline were excluded. CKD was defined as confirmed (>3 mo apart) eGFR In the D:A:D study, 641 individuals developed CKD during 103,185 person-years of follow-up (PYFU; incidence 6.2/1,000 PYFU, 95% CI 5.7-6.7; median follow-up 6.1 y, range 0.3-9.1 y). Older age, intravenous drug use, hepatitis C coinfection, lower baseline eGFR, female gender, lower CD4 count nadir, hypertension, diabetes, and cardiovascular disease (CVD) predicted CKD. The adjusted incidence rate ratios of these nine categorical variables were scaled and summed to create the risk score. The median risk score at baseline was -2 (interquartile range -4 to 2). There was a 1: 393 chance of developing CKD in the next 5 y in the low risk group (risk score = 5, 505 events), respectively. Number needed to harm (NNTH) at 5 y when starting unboosted atazanavir or lopinavir/ritonavir among those with a low risk score was 1,702 (95% CI 1,166-3,367); NNTH was 202 (95% CI 159-278) and 21 (95% CI 19-23), respectively, for those with a medium and high risk score. NNTH was 739 (95% CI 506-1462), 88 (95% CI 69-121), and 9 (95% CI 8-10) for those with a low, medium, and high risk score, respectively, starting tenofovir, atazanavir/ritonavir, or another boosted protease inhibitor. The Royal Free Hospital Clinic Cohort included 2,548 individuals, of whom 94 individuals developed CKD (3.7%) during 18,376 PYFU (median follow-up 7.4 y, range 0.3-12.7 y). Of 2,013 individuals included from the SMART/ESPRIT control arms, 32 individuals developed CKD (1.6%) during 8,452 PYFU (median follow-up 4.1 y, range 0.6-8.1 y). External validation showed that the risk score predicted well in these cohorts. Limitations of this study included limited data on race and no information on proteinuria. Conclusions Both traditional and HIV-related risk factors were predictive of CKD. These factors were used to develop a risk score for CKD in HIV infection, externally validated, that has direct clinical relevance for patients and clinicians to weigh the benefits of certain antiretrovirals against the risk of CKD and to identify those at greatest risk of CKD.Peer reviewe
Calcination effects on CeZrOx geometry and styrene production from ethylbenzene
A series of CeZrOx catalysts was prepared by calcination of hydrothermally obtained metal oxide precipitate at increasing temperatures. The samples were characterized by HRSEM, XRD and Raman spectroscopy, showing a change in morphology and particle size as a function of calcination temperature. Catalytic testing for ethylbenzene dehydrogenation with CO2 showed a decreasing activity per gram with increasing calcination temperature due to the decreasing particle size. However, ethylbenzene dehydrogenation activity per m2 also steadily decreased. Correlation of the catalytic results with Raman analysis showed that not only the number of oxygen vacancies decreases with increasing particle size due to a lower surface area, but also their specific reactivity decreased because of a change in the particle morpholog
Imaging Type VI Secretion-Mediated Bacterial Killing
In the environment, bacteria compete with each other for nutrient availability or to extend their ecological niche. The type VI secretion system contributes to bacterial competition by the translocation of antibacterial effectors from predators into prey cells. The T6SS assembles a dynamic structure—the sheath—wrapped around a tube constituted of the Hcp protein. It has been proposed that by cycling between extended and contracted conformations the sheath acts as a crossbow to propel the Hcp tube toward the target cell. While the sheath dynamics have been studied in monocultures, the activity of the T6SS has not been recorded in presence of the prey. Here, time-lapse fluorescence microscopy of cocultures demonstrates that prey cells are killed upon contact with predator cells. Additional experiments provide evidence that sheath contraction correlates with nearby cell fading and that prey lysis occurs within minutes after sheath contraction. The results support a model in which T6SS dynamics are responsible for T6SS effectors translocation into recipient cells